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Skin cancer is the most common cancer in the United
States. UV radiation in sunlight is the major environ-
mental factor causing skin cancer development. PTEN
(phosphatase and tensin homolog deleted on chro-
mosome 10), a recently discovered tumor suppressor
gene, is frequently mutated, deleted, or epigenetically
silenced in various human cancers. PTEN negatively
regulates the oncogenic phosphatidylinositol 3-kinase
(PI3K)/protein kinase B (AKT) signaling pathways. PTEN
is clearly a critical tumor suppressor for skin cancer in
humans and in mice. This review summarizes the
recent progress in the function of PTEN in the
development of skin cancer, including basal-cell
carcinoma, squamous-cell carcinoma, and melanoma.
The regulation of PTEN by UV radiation is also
discussed in association with skin carcinogenesis.
Understanding the fundamental mechanisms that
lead to the reduction of PTEN function in skin
carcinogenesis and the essential association with UV
radiation opens up new opportunities for molecular
chemoprevention and therapy of skin cancer by
targeting PTEN pathways.
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INTRODUCTION
Skin cancer is the most common type of cancer in the United
States. Each year more than one million new cases are
diagnosed, accounting for more than 40% of all cancers
diagnosed. Skin cancers include basal-cell carcinoma (BCC),
squamous-cell carcinoma (SCC), known as non-melanoma
skin cancer, and melanoma. BCCs and SCCs account for
B80 and 16% of all skin cancers, respectively, whereas
malignant melanomas account for only 4% of all skin cancers
(Bowden, 2004). BCCs and SCCs are both derived from the
basal layer of the epidermis of the skin. BCCs are slow
growing and rarely metastasize, whereas SCCs can be highly
invasive and may metastasize (Bowden, 2004). In contrast,
melanoma is derived from melanocytes and the mortality
associated with melanoma is high. UV irradiation in sunlight
(Ramos et al., 2004; Erb et al., 2008) is the major
environmental factor causing skin cancer. The rising in-
cidence rates of BCC, SCC, and melanoma are highly
associated with increased exposure to UV radiation because
of increased sun exposure caused by sunbed tanning for
cosmetic purposes, increased outdoor activities, changes in
clothing style, increased longevity, and/or ozone depletion
(Rigel, 2008).
PTEN (phosphatase and tensin homolog deleted on
chromosome 10) functions as a highly effective tumor
suppressor in a wide variety of tumor tissues (Suzuki et al.,
2008) by negatively regulating the phosphatidylinositol 3-
kinase (PI3K)/protein kinase B (AKT) pathway (Maehama and
Dixon, 1998). Loss of PTEN function through deletion,
mutation, and/or decreased expression, has been found both
in human sporadic cancers (Steck et al., 1997; Kohno et al.,
1998; Birck et al., 2000; Harima et al., 2001; Byun et al.,
2003) and in hereditary cancer syndromes (Liaw et al., 1997;
Marsh et al., 1997; Harima et al., 2001). This ubiquitous and
evolutionarily conserved signaling cascade influences many
functions, including cell growth, survival, proliferation,
migration, and metabolism (Endersby and Baker, 2008).
Although largely unknown, similar or distinct PTEN involve-
ment may exist in skin carcinogenesis.
The review here is to provide a new perspective of PTEN
regulation and function in skin carcinogenesis, its interaction
with other critical signaling pathways involved in skin
cancer, and its regulation by environmental UV radiation.
Furthermore, the possibility of selectively targeting PTEN
chemoprevention and therapy of skin cancer is also
discussed.
PTEN IN SKIN CANCER
Functional studies supported the hypothesis that PTEN is a
critical tumor suppressor in skin cancer. Loss of PTEN activity
through mutation, deletion, or reduced expression has been
shown to play an important role in skin tumor development.
Germline mutations in PTEN, detected in patients with
Cowden’s disease and Bannayan–Riley–Ruvalcaba syndrome
(Bonneau and Longy, 2000), lead to the loss of PTEN
function, which increases the risk of tumorigenesis in skin
as well as in other organs (Liaw et al., 1997; Trojan et al.,
2001).
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PTEN in BCC
Loss of PTEN function may be critical for BCC formation
through activating Sonic Hedgehog (Shh) signaling. BCC, at
the molecular level, is characterized by aberrant activation of
Shh signaling, usually because of mutations either in the
patched (Ptc) or smoothened (Smo) genes (Reifenberger,
2007), or because of hyperactivation of this pathway. It is
interesting that PTEN may be critical for Shh signaling.
Recent studies have shown that PI3K/AKT activation is
essential for Shh signaling by controlling PKA-mediated
Gli inactivation (Riobo et al., 2006). Although little is
known regarding PTEN function in BCC, loss of PTEN
function in BCC would upregulate the PI3K/AKT pathway to
stimulate even low-level ligand-dependent or ligand-inde-
pendent Shh signaling caused by mutations in Hedgehog
pathway components. Although deletions of 10q23,
where PTEN is located, were found to be an infrequent event
in BCC (Quinn et al., 1994), the inactivation of PTEN by
other mechanisms may play an important role in BCC
development.
PTEN in SCC
The critical role of genetic PTEN suppression in SCC has been
shown in humans and in mice. The tumor suppressing
function of PTEN in SCC has been shown in patients with
Cowden’s disease, in vitro in human keratinocytes, and
in vivo, using a chemical skin carcinogenesis model. The
association of cutaneous SCC with Cowden’s disease has also
been reported (Nuss et al., 1978; Camisa et al., 1984). The
decreasing levels of PTEN expression are correlated with a
malignant transformation of the skin induced by UVA
(315–400nm), as shown by the formation of SCC in nude
mice (He et al., 2006).
Mice with PTEN deletion and mutation are highly
susceptible to tumor induction (Suzuki et al., 1998).
Conditional knockout of PTEN in skin leads to neoplasia in
skin (Li et al., 2002; Suzuki et al., 2003; Backman et al.,
2004), thereby showing the pivotal role of PTEN in skin
cancer development. PTEN deficiency in mice causes
increases in cell proliferation, apoptotic resistance, stem-cell
renewal/maintenance, centromeric instability, and DNA
double-strand breaks (Groszer et al., 2001; Kimura et al.,
2003; Wang et al., 2006; He et al., 2007; Shen et al., 2007;
Yanagi et al., 2007), which can enhance susceptibility to
carcinogens and the occurrence of secondary genetic or
epigenetic alterations that can lead to skin cancer
development.
Complex mechanisms may mediate the inactivation of
PTEN. Somatic mutations, deletion, or promoter hypermethy-
lation of PTEN have not been detected in SCCs of human skin
(Quinn et al., 1994; Kubo et al., 1999; Murao et al., 2006).
Thus, the inactivation of PTEN by other mechanisms may be
involved in SCC pathogenesis, including inactivation of the
protein and/or epigenetic silencing, and the mechanism(s) by
which its function and activity are regulated remain to be
established.
Loss of PTEN function may occur as an early or late event,
and PTEN loss has contributed to skin cancer development.
Immunohistochemical studies have shown that, in mouse
skin tumors, PTEN immunoreactivity was clearly confined to
differentiating areas of the papillomas, and to the most
differentiating areas in SCC samples, whereas PTEN staining
is lost in non-differentiating infiltrative areas of SCCs,
suggesting the expression and localization of PTEN in tumor
sections that represent the different stages of mouse skin
carcinogenesis (Segrelles et al., 2002).
PTEN in melanoma
Loss of PTEN function has been implicated in the develop-
ment of melanoma (Wu et al., 2003). A high frequency of
PTEN mutations has also been detected in malignant
melanomas (Bonneau and Longy, 2000). On the basis of
melanoma cell lines and mainly metastatic tumors, many
studies also showed that PTEN played a significant role in
sporadic cutaneous melanomas (Tsao et al., 1998). PTEN
inactivation was a late event likely related to melanoma
progression rather than to initiation, and the translocation of
PTEN expression from nuclear predominance to cytoplasmic
predominance occurs from melanocyte to primary melanoma
to metastasis melanoma. The potential genetic interaction
among NRAS, BRAF, and PTEN may play a critical role in
melanoma development (Tsao et al., 2004).
Loss of PTEN function also increases AKT3 activation in
melanoma. AKT3 protein, but not AKT1 or AKT2 protein, was
found to be increased in melanoma cell lines when
compared with normal melanocytes. Mechanisms of AKT3
deregulation occurred through a combination of overexpres-
sion of AKT3, accompanying copy number increases of the
gene, and decreased PTEN protein function, occurring
through loss or haploinsufficiency of the PTEN gene (Stahl
et al., 2004; Robertson, 2005).
PTEN REGULATION BY UV RADIATION
Recent studies show that UV radiation regulates PTEN
function in skin cells. UV exposure causes gene alteration
of PTEN (Hocker and Tsao, 2007). Inducing Egr-1 by
exposing cells to acute UVC (100–280nm) upregulates the
expression of the PTEN messenger RNA and protein, and
leads to apoptosis. Loss of Egr-1 expression, which often
occurs in human cancers, could deregulate the PTEN gene
and contribute to the radiation resistance of some cancer
cells (Virolle et al., 2001).
Our recent evidence shows that chronic UVA radiation
decreased PTEN expression, and this decrease is required for
enhanced cell survival in the transformed human keratino-
cytes, suggesting that PTEN might be critical for skin
carcinogenesis induced by UVA (He et al., 2006). PTEN
increases sensitivity to cell death in response to several
apoptotic stimuli, including UV irradiation and treatment
with tumor necrosis factor a, by negatively regulating the
PI3K/AKT pathway (Stambolic et al., 1998), implying that
PTEN alterations might be involved in UV-induced skin
cancer. UVB (280–315 nm) was also reported to inhibit PTEN
by increasing PTEN phosphorylation in human dermal
fibroblasts, as phosphorylation of PTEN downregulates its
lipid phosphatase and protein stability (Oh et al., 2006). Thus
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UV-mediated inhibition of PTEN function may further
enhance AKT activation induced by UV radiation.
It is likely that multiple complex interactions at the
transcriptional, post-transcriptional, and/or post-translational
levels are involved. Systematic characterization of PTEN
regulation by UV radiation will not only advance our
knowledge of the fundamental mechanisms of PTEN involve-
ment in skin cancer, but also facilitate the development of
feasible approaches to prevent PTEN suppression because of
chronic UV exposure.
Furthermore, UV-induced production of reactive oxygen
species and the resultant oxidative stress exposure plays an
important role in photocarcinogenesis caused by UV, and
reactive oxygen species are believed to be involved in many
inflammatory skin disorders, skin cancer formation, photo-
toxicity, and skin aging. PTEN activity can be inhibited by
reactive oxygen species (Gimm et al., 2000), implying that
reduced PTEN activity by UV-induced reactive oxygen
species formation might be involved in UV-induced skin
tumorigenesis.
CONCLUSIONS AND FUTURE DIRECTIONS
PTEN plays a critical role in skin homeostasis and is a
critical tumor suppressor in the prevention of skin
carcinogenesis, as shown in humans and in mice. This has
positioned PTEN in a central role of tumor suppression by
antagonizing PI3K/AKT pathways in skin carcinogenesis.
Proper function of PTEN is essential for maintaining the
balance in cell proliferation and survival in epidermal cells,
including keratinocytes and melanocytes in skin, to prevent
transformation.
In addition, UV radiation, the major risk factor causing
skin cancer, suppresses PTEN expression, indicating that
PTEN may be the critical target for UV-induced skin
tumorigenesis. As skin cancer is the most common malig-
nancy in the United States, elucidating the mechanisms of
PTEN function, and its regulation and function in the
pathogenesis of BCC, SCC, and melanoma will have a broad
impact in improving patients’ quality of life and reduce the
high morbidity associated with these cancers. Targeted PTEN,
directly or by interfering with upstream proteins regulating
PTEN activity, presents a new and more effective preventive
and therapeutic approach in reducing skin cancer burden, as
suggested in other cancers. Recently, the protective nature of
phytoestrogens has been shown to be partially mediated by
increasing PTEN expression, indicating that PTEN may be
one of the critical molecular targets for skin cancer
prevention and treatment.
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